KZA kazia therapeutics limited
Add to My Watchlist 0.00% ! 8.0¢

Price Target Announced at $17.00/Share by HC Wainwright & Co. (US Price)

  1. VitaminD
    8,243 Posts.
    lightbulb Created with Sketch. 897
    clock Created with Sketch.
    08/01/21
    10:44
    Post #: 50028595
    Column 1 Column 2 Column 3 Column 4 Column 5
    0 05/01/2021 22:18 PM   Dow Jones Kazia Therapeutics Initiated at Buy by HC Wainwright & Co.
    1   22:18 PM   Dow Jones Kazia Therapeutics Price Target Announced at $17.00/Share by HC Wainwright & Co.
    USA price

    Column 1
    0 Kazia Therapeutics Price Target Announced at $17.00/Share by HC Wainwright & Co.
    1 05/01/2021  10:18PM
    2 Ratings actions from Benzinga: https://www.benzinga.com/stock/KZIA/ratings[/P] (END) Dow Jones Newswires
    January 05, 2021 06:18 ET (11:18 GMT)


    Previous Stories
    1 05/01/2021  10:18PM Kazia Therapeutics Initiated at Buy by HC Wainwright & Co.
    KZA Price at posting: $1.31 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.